EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Real-World Impact of Tezepelumab on Asthma Exacerbations, Healthcare Resource Utilization, and Costs in US Patients with Severe Asthma: CROSSROADS-1

Santiago Zuluaga Sanchez, Jessica K DeMartino, Magdaliz Gorritz, Christopher S Ambrose iD, Rifat Tuly, Jean-Pierre Llanos, Chi-Chang Chen, Andrew W Lindsley, Lee Baylis, Weily Soong iD, Laren Tan

Journal of Asthma and Allergy · 2026-10 · Volume 19 · 1-15

DOI: 10.2147/jaa.s620862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asthma and Allergy, 2026-10. Verfasst von Santiago Zuluaga Sanchez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics, Amgen Ltd, Uxbridge, UK. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

asthma exacerbationshealth insurance claimshealthcare resource utilizationreal-world evidencesevere asthmatezepelumab

Autor:innen und Institutionen

  • Health Economics, Amgen Ltd, Uxbridge, UK.
  • Respiratory and Immunology, AstraZeneca, Wilmington, DE, USA.
  • Real World Country Solutions, IQVIA Inc, Wayne, PA, USA.
  • BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
  • Global Medical Affairs, Amgen, Thousand Oaks, CA, USA.
  • US Medical Affairs, Amgen, Thousand Oaks, CA, USA.

ORCID-Profile: Christopher S Ambrose, Weily Soong

Zitieren

APA

Zuluaga Sanchez, S., DeMartino, J. K., Gorritz, M., Ambrose, C. S., Tuly, R., Llanos, J. P., Chen, C. C., Lindsley, A. W., Baylis, L., Soong, W., & Tan, L. (2026). Real-World Impact of Tezepelumab on Asthma Exacerbations, Healthcare Resource Utilization, and Costs in US Patients with Severe Asthma: CROSSROADS-1. Journal of Asthma and Allergy, Volume 19, 1-15. https://doi.org/10.2147/jaa.s620862

Vancouver

Zuluaga Sanchez S, DeMartino JK, Gorritz M, Ambrose CS, Tuly R, Llanos JP, et al. Real-World Impact of Tezepelumab on Asthma Exacerbations, Healthcare Resource Utilization, and Costs in US Patients with Severe Asthma: CROSSROADS-1. Journal of Asthma and Allergy. 2026;Volume 19:1-15. doi:10.2147/jaa.s620862

BibTeX
@article{ZuluagaSanchez2026,
  author = {Zuluaga Sanchez, Santiago and DeMartino, Jessica K and Gorritz, Magdaliz and Ambrose, Christopher S and Tuly, Rifat and Llanos, Jean-Pierre and Chen, Chi-Chang and Lindsley, Andrew W and Baylis, Lee and Soong, Weily and Tan, Laren},
  title = {Real-World Impact of Tezepelumab on Asthma Exacerbations, Healthcare Resource Utilization, and Costs in US Patients with Severe Asthma: CROSSROADS-1},
  journal = {Journal of Asthma and Allergy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/jaa.s620862}
}
Kostenlos starten →